Home βΊ Calculator βΊ CASIF Dividend Calculator 2026
CASIF Dividend DRIP Calculator 2026
1538.46% YieldHealthcareCASI Pharmaceuticals, Inc. Β· OTC
Price: $0.13 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
π‘ What-if scenarios
Click to apply scenario to the calculator
π― When CASIF pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your CASIF snowball π
$10,000 in CASIF β $94474942298006.06M in 10 years Β· $7,807,298,805,292,101,000.00/month
About CASI Pharmaceuticals, Inc. (CASIF) β Dividend Analysis 2026
CASI Pharmaceuticals, Inc. operates as a biopharmaceutical firm, focusing on the development and commercialization of therapeutic and pharmaceutical products across the People's Republic of China, the United States, and international territories. The company's offerings include EVOMELA, an intravenous formulation of melphalan, which serves as a conditioning treatment before stem cell transplantation and as palliative care for patients with multiple myeloma. Its hematology/oncology pipeline is robust, featuring CNCT19, an investigative autologous CD19 CAR-T product; BI-1206, a novel anti-FcΞ³RIIB antibody designed for treating solid tumors and relapsed/refractory non-Hodgkin lymphoma; CB-5339, an innovative VCP/p97 inhibitor targeting valosin-containing protein (VCP)/p97 pathways crucial for protein homeostasis, DNA damage response, and cellular stress in various malignancies; CID-103, a human IgG1 anti-CD38 monoclonal antibody; and Thiotepa, a chemotherapeutic agent with diverse indications, including its use as a conditioning regimen prior to certain allogeneic hematopoietic stem cell transplants. CASI Pharmaceuticals maintains licensing agreements with entities such as Juventas Cell Therapy Ltd., BioInvent International AB, Black Belt Therapeutics Limited, Cleave Therapeutics, Inc., and Acrotech Biopharma L.L.C., primarily for the development and commercialization of its commercial product, EVOMELA. The company was founded in 1991 and is headquartered in Beijing, People's Republic of China.
Compare CASIF with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CASIF DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open CASIF position with:
π CASIF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CASIF.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 1538.46% | 1535.66% | $153,846 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 1307.69% | 1304.89% | $130,769 / yr |
| πΊπΈ US Taxable (20%) | 20% | 1230.77% | 1227.97% | $123,077 / yr |
| π¬π§ UK ISA | 0% | 1538.46% | 1535.66% | $153,846 / yr |
| π¬π§ UK Taxable | 8.75% | 1403.84% | 1401.04% | $140,384 / yr |
| π¨π¦ TFSA | 0% | 1538.46% | 1535.66% | $153,846 / yr |
| π¨π¦ CA Taxable | 25% | 1153.85% | 1151.05% | $115,385 / yr |
| π¦πΊ Super (pension) | 15% | 1307.69% | 1304.89% | $130,769 / yr |
| π¦πΊ AU Taxable | 30% | 1076.92% | 1074.12% | $107,692 / yr |
| π©πͺ DE Taxable | 26.375% | 1132.69% | 1129.89% | $113,269 / yr |
| π«π· FR Taxable | 30% | 1076.92% | 1074.12% | $107,692 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
π― CASIF Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
π CASIF Dividend Payment Schedule
CASIF pays quarterly β 4 times per year. Next ex-div: TBD.
π CASIF vs Healthcare Benchmarks
How CASIF compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CASIF sourced from FMP /financial-growth endpoint β real data, not estimates.
ποΈ CASIF Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Other | 2026-03-18 | 11,231 | $2.67 | $30.0K | ||
| Other | 2026-03-18 | 20,000 | $3.59 | $71.8K | ||
| Other | 2026-03-18 | 11,231 | $1.93 | $21.7K | ||
| Other | 2026-03-18 | 11,231 | $1.26 | $14.2K | ||
| Other | 2026-03-18 | 11,231 | $1.93 | $21.7K | ||
| Other | 2026-03-18 | 11,231 | $2.67 | $30.0K | ||
| Other | 2026-03-18 | 11,231 | $1.26 | $14.2K | ||
| Other | 2026-03-18 | 4,000 | $1.93 | $7.7K | ||
| Other | 2026-03-18 | 10,000 | $5.78 | $57.8K | ||
| Other | 2027-06-18 | 5,000 | $2.67 | $13.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst Price Target
Wall Street consensusAnalyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CASIF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
CASI Pharmaceuticals, Inc. (CASIF) is currently trading at $0.13, 100% below its 52-week high. The current dividend yield is 1538.46% based on an annual payout of $2.00 per share.
CASIF (CASI Pharmaceuticals, Inc.) β 1538.46% Dividend Yield Analysis
CASI Pharmaceuticals, Inc. (CASIF) is a healthcare stock currently trading at $0.13 with a dividend yield of 1538.46%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
- Above-average yield (1538.46%) may signal elevated risk β verify sustainability.
Auto-generated from live market data. For educational purposes only β not financial advice.